Australia's most trusted source of pharma news
Saturday, 16 November 2019
News Headlines
Contact Pharma in Focus
If you would like to know more about Pharma in Focus then write, email or phone us.
| Postal Address: | Suite 202 117 Old Pittwater Road Brookvale NSW 2100 |
| Advertising: | +61 2 9938 4381 |
| Editorial: | +61 2 9939 0981 |
| Subscriptions & Access: | +61 2 9939 1881 |
| Fax: | +61 2 9938 5681 | Email: | contact@pharmainfocus.com.au |
If you would like specific information then please fill in the form below and send it to us.
Pipeline Monitor
BMS I-Os target liver
Combo under priority review for HCC in US.
Combo under priority review for HCC in US.
Top of the Hill
The pill or the cure
New gene therapies a challenge for payers.
New gene therapies a challenge for payers.
Approvals Action
Novartis' newest drug
First-ever oral SPMS drug Mayzent arrives.
First-ever oral SPMS drug Mayzent arrives.